Vivos Therapeutics Stock Forecast

Sell candidate since Jun 09, 2026 Loss -35.28%

The Vivos Therapeutics, Inc. stock price fell by -9.05% on the last day (Thursday, 2nd Jul 2026) from $0.498 to $0.453. During the last trading day the stock fluctuated 14.22% from a day low at $0.445 to a day high of $0.508. The price has fallen in 6 of the last 10 days and is down by -11.35% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -43 thousand shares and in total, 392 thousand shares were bought and sold for approximately $177.62 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -48.26% during the next 3 months and, with a 90% probability hold a price between $0.157 and $0.417 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

VVOS Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 22, 2026, and so far it has risen 12.68%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Vivos Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.460 and $0.596. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Vivos Therapeutics, Inc. stock

Vivos Therapeutics, Inc. finds support from accumulated volume at $0.441 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0633 between high and low, or 14.22%. For the last week the stock has had daily average volatility of 15.88%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VVOS) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Vivos Therapeutics, Inc. to open at $0.469, and during the day (based on 14 day Average True Range), to move between $0.409 and $0.498, which gives a possible trading interval of +/-$0.0891 (+/-21.79%) up or down from last closing price. If Vivos Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 21.79% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.455 (0.29%) than the support at $0.441 (2.60%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Vivos Therapeutics, Inc. stock A Buy?

Vivos Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.195 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $0.469 ( 3.45%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk